The Vk*MYC genetically engineered mouse model of MM is based on the sporadic AID-induced activation of human MYC in a single germinal center (GC) B-cell, in a mouse strain, C57Bl/6, that spontaneously develops monoclonal gammopathy. The gene discussed is MYC; the disease is monoclonal gammopathy.